This scholarly profile was discovered from public research metadata and has not yet been claimed. Is this your research profile?
Hiroaki Shimokawa
UnverifiedResearcher · JP
Publications
10
Citations
19357
max across sources
Profile views
5
bot-filtered
Verification
L0
Overview
AI-generatedHiroaki Shimokawa (RTX-00000077) based in JP is a researcher on ResearchTrics. Lists research interests: cardiac imaging and diagnostics, cardiovascular function and risk factors, heart failure treatment and management, nitric oxide and endothelin effects, pulmonary hypertension research and treatments. Has 10 publications recorded, including "International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology" (2018), "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management" (2018), "Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease" (2017).
An AI overview generated from this profile’s verified records — an interpretation, not a verified statement.
Research interests
- cardiac imaging and diagnostics
- cardiovascular function and risk factors
- heart failure treatment and management
- nitric oxide and endothelin effects
- pulmonary hypertension research and treatments
Publications (20)
- International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology1621 cites
European Heart Journal · 2018 · DOI
- International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology1621 cites
European Heart Journal · 2018 · DOI
- International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management907 cites
European Heart Journal · 2018 · DOI
- International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management907 cites
European Heart Journal · 2018 · DOI
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease9517 cites
New England Journal of Medicine · 2017 · DOI
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease9517 cites
New England Journal of Medicine · 2017 · DOI
- International standardization of diagnostic criteria for microvascular angina856 cites
International Journal of Cardiology · 2017 · DOI
- International standardization of diagnostic criteria for microvascular angina856 cites
International Journal of Cardiology · 2017 · DOI
- Endothelial dysfunction and vascular disease - a 30th anniversary update935 cites
Acta Physiologica · 2015 · DOI
- Endothelial dysfunction and vascular disease - a 30th anniversary update935 cites
Acta Physiologica · 2015 · DOI
- Heart Failure: Preventing Disease and Death Worldwide1714 cites
ESC Heart Failure · 2014 · DOI
- Heart Failure: Preventing Disease and Death Worldwide1714 cites
ESC Heart Failure · 2014 · DOI
- Endothelial dysfunction and vascular disease801 cites
Acta Physiologica · 2009 · DOI
- Endothelial dysfunction and vascular disease801 cites
Acta Physiologica · 2009 · DOI
- Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice726 cites
Journal of Clinical Investigation · 2000 · DOI
- Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice726 cites
Journal of Clinical Investigation · 2000 · DOI
